Seong Heon Kim

Statistics

Publications

Citations

1.1K

H-Index

Active since

1997

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Scripps Research Institute

WuXi AppTec (China)

United States Military Academy

Ligand Pharmaceuticals (United States)

Seong Heon Kim is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, drug discovery, and pharmacology.

ORCID

Publications per year

1997–2023

Publications

Total Synthesis of the Vancomycin Aglycon

Dale L. Boger, Susumu Miyazaki, Seong Heon Kim et al. · Journal of the American Chemical Society · 1999 · 202 citations

Pharmacy, Chemistry, Medicinal Chemistry +17

Diastereoselective Total Synthesis of the Vancomycin Aglycon with Ordered Atropisomer Equilibrations

Dale L. Boger, Susumu Miyazaki, Seong Heon Kim et al. · Journal of the American Chemical Society · 1999 · 133 citations

Natural Sciences, Chemistry, Medicinal Chemistry +5

First and Second Generation Total Synthesis of the Teicoplanin Aglycon

Dale L. Boger, Seong Heon Kim, Yoshiki Mori et al. · Journal of the American Chemical Society · 2001 · 115 citations

Pharmacy, Chemistry, Medicinal Chemistry +12

A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection

Chung‐Her Jenh, Mary Ann Cox, Long Cui et al. · BMC Immunology · 2012 · 84 citations · Full text

Life Sciences, Immunology, Pharmacology +17

A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection

Chung‐Her Jenh, Mary Ann Cox, Long Cui et al. · BMC Immunology · 2012 · 83 citations · Full text

Life Sciences, Immunology, Pharmacology +17

1–5 of 22